Study identifier:D1843R00300
ClinicalTrials.gov identifier:NCT04072523
EudraCT identifier:N/A
CTIS identifier:N/A
An Observational, Cross sectional Study to assess the Prevalence of Heart Failure in Type 2 Diabetes Patients in India
Type 2 Diabetes
N/A
No
-
All
621
Observational
N/A
Allocation: N/A
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -
Verified 01 Feb 2022 by AstraZeneca
AstraZeneca
-
No locations available
Arms | Assigned Interventions |
---|---|
Observational Study Investigational Product NA Patients : Type 2 Diabetic Patients | - |